Haleos Labs Limited (NSE:HALEOSLABS)
India · Delayed Price · Currency is INR 1,596.30
+197.50 (14.12%)
Nov 12, 2026, 3:29 PM IST
Haleos Labs Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3,345 | 3,338 | 3,447 | 3,060 | 3,156 | 3,501 | |
Revenue Growth | -0.90% | -3.17% | 12.67% | -3.04% | -9.86% | 31.81% |
Cost of Revenue | 2,102 | 2,062 | 2,177 | 2,097 | 2,289 | 2,605 |
Gross Profit | 1,243 | 1,276 | 1,270 | 962.44 | 866.62 | 895.96 |
Selling, General & Admin | 693.37 | 665.92 | 604.21 | 527.38 | 440.44 | 400.72 |
Other Operating Expenses | 180.3 | 153.81 | 214.28 | 122.85 | 137.82 | 148.64 |
Operating Expenses | 1,037 | 975.41 | 968.46 | 799.6 | 686.15 | 649.42 |
Operating Income | 205.91 | 300.9 | 301.28 | 162.84 | 180.47 | 246.54 |
Interest Expense | -66.87 | -61.21 | -84.58 | -99.53 | -64.24 | -57 |
Interest & Investment Income | 3.72 | 3.72 | 3.08 | 2.76 | 3.95 | 3.25 |
Currency Exchange Gain (Loss) | 0.95 | 0.95 | 15.92 | 18.22 | 3.1 | 9.38 |
Other Non Operating Income (Expenses) | 15.45 | 15.45 | 25.89 | 14.19 | 19.14 | -2.65 |
EBT Excluding Unusual Items | 159.15 | 259.8 | 261.59 | 98.48 | 142.43 | 199.52 |
Gain (Loss) on Sale of Assets | -0.01 | -0.01 | 0.31 | -0.01 | -0.01 | 0.87 |
Asset Writedown | -7.82 | -7.82 | - | - | - | - |
Other Unusual Items | - | - | - | - | 23.52 | 126.92 |
Pretax Income | 151.31 | 251.96 | 261.9 | 98.47 | 165.93 | 327.31 |
Income Tax Expense | 45.39 | 73.96 | 74.58 | 35.19 | 52.16 | 74.31 |
Earnings From Continuing Operations | 105.93 | 178 | 187.32 | 63.28 | 113.77 | 253 |
Minority Interest in Earnings | 23.62 | -4.88 | 13.77 | 27.65 | 0.85 | 0.22 |
Net Income | 129.54 | 173.12 | 201.09 | 90.93 | 114.63 | 253.22 |
Net Income to Common | 129.54 | 173.12 | 201.09 | 90.93 | 114.63 | 253.22 |
Net Income Growth | -30.72% | -13.91% | 121.15% | -20.68% | -54.73% | 86.79% |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 |
Shares Change | -0.01% | - | - | - | - | - |
EPS (Basic) | 42.85 | 57.26 | 66.51 | 30.08 | 37.92 | 83.76 |
EPS (Diluted) | 42.85 | 57.26 | 66.51 | 30.08 | 37.92 | 83.76 |
EPS Growth | -30.71% | -13.91% | 121.15% | -20.68% | -54.73% | 86.79% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -612.34 | -206.39 | 187.06 | 34.38 | -338.56 | -623.94 |
Free Cash Flow Per Share | -202.55 | -68.27 | 61.87 | 11.37 | -111.98 | -206.38 |
Dividend Per Share | 1.500 | 1.500 | 1.500 | 1.500 | 1.500 | 1.500 |
Dividend Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Gross Margin | 37.16% | 38.24% | 36.83% | 31.46% | 27.46% | 25.59% |
Operating Margin | 6.16% | 9.01% | 8.74% | 5.32% | 5.72% | 7.04% |
Profit Margin | 3.87% | 5.19% | 5.83% | 2.97% | 3.63% | 7.23% |
Free Cash Flow Margin | -18.30% | -6.18% | 5.43% | 1.12% | -10.73% | -17.82% |
EBITDA | 361.9 | 449.08 | 444.58 | 305.31 | 281.96 | 341.75 |
EBITDA Margin | 10.82% | 13.45% | 12.90% | 9.98% | 8.94% | 9.76% |
D&A For EBITDA | 155.99 | 148.19 | 143.29 | 142.47 | 101.49 | 95.21 |
EBIT | 205.91 | 300.9 | 301.28 | 162.84 | 180.47 | 246.54 |
EBIT Margin | 6.16% | 9.01% | 8.74% | 5.32% | 5.72% | 7.04% |
Effective Tax Rate | 29.99% | 29.35% | 28.48% | 35.74% | 31.43% | 22.70% |
Revenue as Reported | 3,370 | 3,362 | 3,496 | 3,098 | 3,186 | 3,518 |
Advertising Expenses | - | 11.53 | 8.24 | 3.71 | 5.19 | 0.9 |